HOAG MEMORIAL HOSPITAL PRESBYTERIAN
- Country
- 🇺🇸United States
- Ownership
- -
- Established
- 1952-01-01
- Employees
- -
- Market Cap
- -
Clinical Trials
30
Trial Phases
3 Phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (23 trials with phase data)• Click on a phase to view related trials
A Phase I Trial of 61Cu-NODAGA-PSMA for Patients with Prostate Cancer
- First Posted Date
- 2024-12-16
- Last Posted Date
- 2024-12-16
- Lead Sponsor
- Hoag Memorial Hospital Presbyterian
- Target Recruit Count
- 8
- Registration Number
- NCT06736054
- Locations
- 🇺🇸
Hoag Memorial Hospital Presbyterian, Irvine, California, United States
Study of Dotatate Imaging in Breast Cancer
- Conditions
- Breast Cancer Stage IV
- First Posted Date
- 2023-05-30
- Last Posted Date
- 2024-02-12
- Lead Sponsor
- Hoag Memorial Hospital Presbyterian
- Target Recruit Count
- 30
- Registration Number
- NCT05880394
- Locations
- 🇺🇸
Hoag Memorial Hospital Presbyterian, Irvine, California, United States
Pancreatic Cancer Early Detection Registry
- Conditions
- Pancreatic Cancer
- First Posted Date
- 2022-08-29
- Last Posted Date
- 2024-10-11
- Lead Sponsor
- Hoag Memorial Hospital Presbyterian
- Target Recruit Count
- 326
- Registration Number
- NCT05519930
- Locations
- 🇺🇸
Hoag Memorial Hospital Presbyterian, Newport Beach, California, United States
18F-fluoroestradiol (FES) PET/CT for Breast Cancer
- Conditions
- Breast Cancer
- First Posted Date
- 2021-05-12
- Last Posted Date
- 2023-09-28
- Lead Sponsor
- Hoag Memorial Hospital Presbyterian
- Target Recruit Count
- 124
- Registration Number
- NCT04883814
- Locations
- 🇺🇸
Hoag Memorial Hospital Presbyterian, Irvine, California, United States
A Diagnostic Study of CD38-Targeted ImmunoPET of Myeloma
- Conditions
- Multiple Myeloma
- Interventions
- Drug: 89Zr-daratumumab PET/CT
- First Posted Date
- 2021-03-24
- Last Posted Date
- 2023-06-27
- Lead Sponsor
- Hoag Memorial Hospital Presbyterian
- Target Recruit Count
- 60
- Registration Number
- NCT04814615
- Locations
- 🇺🇸
Hoag Memorial Hospital Presbyterian, Irvine, California, United States
🇺🇸University of Miami, Miami, Florida, United States
- Prev
- 1
- 2
- 3
- 4
- 5
- 6
- Next
News
PanTher Therapeutics Initiates Phase 1b Trial of Novel Localized Chemotherapy Film for Pancreatic Cancer
PanTher Therapeutics has dosed the first patient in a Phase 1b clinical trial of PTM-101, an innovative thin film formulation of paclitaxel designed for direct tumor placement in pancreatic ductal adenocarcinoma.
Regeneration Biomedical Reports Promising Phase 1 Results for Direct Brain Injection of Stem Cells in Alzheimer's Disease
Regeneration Biomedical's Phase 1 trial of Wnt-activated autologous stem cells injected directly into the brain showed 80% of Alzheimer's patients improved cognitive scores and normalized biomarkers.
NUCLIDIUM's Copper-Based Radiotracer Shows Enhanced Imaging Performance in First Prostate Cancer Patient
NUCLIDIUM's 61Cu-NODAGA-PSMA I&T radiotracer successfully imaged the first patient in a phase 1 trial, showing more osseous lesions than FDA-approved 18F-piflufolastat at 1 hour post-injection.